Cargando…

971. Breakthrough Invasive Fungal Infections (IFI) in Acute Leukemia (AL) Patients Receiving Antifungal Prophylaxis

BACKGROUND: A major challenge in patients with AL receiving chemotherapy is to decrease the risk of IFI during the prolonged neutropenic period. Even with antifungal prophylaxis, the incidence of breakthrough IFI can be as high as 14%. Our objectives were to determine the incidence of all IFI and br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wasylyshyn, Anastasia, Castillo, Caroline, Linder, Kathleen A, Zhou, Shiwei, Kauffman, Carol A, Miceli, Marisa H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253146/ http://dx.doi.org/10.1093/ofid/ofy209.087

Ejemplares similares

1736. Evaluation of Targeted vs. Universal Antifungal Prophylaxis (AP) for Invasive Fungal Infections (IFI) After Lung Transplant (LTx)
por: Linder, Kathleen A, et al.
Publicado: (2019)

1150. Breakthrough Invasive Fungal Disease (IFD) in Patients with Acute Myeloid Leukemia (AML)
por: Wasylyshyn, Anastasia, et al.
Publicado: (2020)

Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid Leukemia
por: Wasylyshyn, Anastasia I., et al.
Publicado: (2021)

COVID-19-Associated Pulmonary Aspergillosis at an Academic Medical Center in the Midwestern United States
por: Wasylyshyn, Anastasia I., et al.
Publicado: (2021)

2040. Clinical Application of Aspergillus Lateral Flow Device (AspLFD) in Bronchoalveolar Lavage (BAL) Fluid of Patients with Classic Risk Factors for Invasive Pulmonary Aspergillosis (IPA)
por: Linder, Kathleen A, et al.
Publicado: (2018)

742. Breakthrough Invasive Fungal Infections with Isavuconazonium Sulfate versus Voriconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia (AML) who Received Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

Performance of Aspergillus Galactomannan Lateral Flow Assay on Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis
por: Linder, Kathleen A., et al.
Publicado: (2020)

Blastomycosis: A Review of Mycological and Clinical Aspects
por: Linder, Kathleen A., et al.
Publicado: (2023)

Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study
por: Dabas, Yubhisha, et al.
Publicado: (2021)

2042. Clinical Application of AspID PCR Alone and in Combination with Aspergillus Lateral Flow Device (AspLFD) in Bronchoalveolar Lavage (BAL) Fluid of Patients with Classic Risk Factors for Invasive Pulmonary Aspergillosis (IPA)
por: Linder, Kathleen A, et al.
Publicado: (2018)

Diagnostic Performance of Bronchoalveolar Lavage (1,3)-β-d-Glucan Assay for Pneumocystis jirovecii Pneumonia
por: Zhou, Shiwei, et al.
Publicado: (2020)

Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
por: Rinaldi, Matteo, et al.
Publicado: (2021)

1220. Comparing Breakthrough Fungal Infections in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients Receiving Prophylaxis with Different Azoles
por: Chen, Catherine, et al.
Publicado: (2023)

Invasive fungal infection (IFI) in pediatric leukemia: better outcome with ACT
por: Shin, Ok Sarah
Publicado: (2017)

Italian concerto, BWV 971 Chromatic fantasia and fugue, BWV 903 ; French suites BWV 812 & 813 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1994)

Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis
por: Gatti, Milo, et al.
Publicado: (2021)

2048. Comparison Between Endpoint and Real-Time (RT) Polymerase Chain Reaction (PCR) for the Diagnosis of Pneumocystis Pneumonia (PCP)
por: Zhou, Shiwei, et al.
Publicado: (2018)

971 Clinical Spectrum of Group B Streptococcol Cellulitis-Adenitis Syndrome
por: Pretorius, Christopher C., et al.
Publicado: (2014)

430 Patients with Prolonged (>10 days) Neutropenia Displayed Similar IFI Rates Regardless of Hematologic Diagnosis and Chemotherapy Status: A Challenge to Antifungal Prophylaxis Decisions
por: Saxinger, Lynora, et al.
Publicado: (2014)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

Pro/con debate: Antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics
por: Eggimann, Philippe, et al.
Publicado: (2006)

971. The Role of Inflammation and Innate Effectors in Passive Immunization for Acinetobacter baumannii Infections
por: Nielsen, Travis B, et al.
Publicado: (2019)

Successful treatment of breakthrough disseminated Trichosporon asahii fungemia in a patient with acute myeloid leukemia receiving itraconazole prophylaxis
por: Karigane, Daiki, et al.
Publicado: (2017)

1301. Breakthrough Invasive Fungal Infections based on CYP2C19 Levels in Patients Who were on Voriconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) undergoing Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients
por: Breitkopf, Robert, et al.
Publicado: (2023)

1542. Infectious Complications in Patients Following Umbilical Cord Blood Transplant (UCBT) for Hematologic Malignancy
por: Linder, Kathleen A, et al.
Publicado: (2018)

Risk factors for breakthrough urinary tract infection in children with vesicoureteral reflux receiving continuous antibiotic prophylaxis
por: Su, Dequan, et al.
Publicado: (2022)

Effect of Flow Aids on Mucoadhesive Properties of Polymeric Discs of Polyoxyethylene and Carbopol 971P
por: Bele, M. H., et al.
Publicado: (2010)

971. Pharmacokinetic Estimation Analysis of Multi-Dose Regimens of Dalbavancin for Treatment of Osteomyelitis or Bacteremia
por: Volk, Cecilia, et al.
Publicado: (2023)

High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan
por: Tang, Jih-Luh, et al.
Publicado: (2015)

Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy
por: Linder, Kathleen A, et al.
Publicado: (2019)

Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)

Fungal Infections
por: Kauffman, Carol A.
Publicado: (2009)

Increased Ifi202b/IFI16 expression stimulates adipogenesis in mice and humans
por: Stadion, Mandy, et al.
Publicado: (2018)

Histoplasmosis and Blastomycosis in Solid Organ Transplant Recipients
por: Kauffman, Carol A., et al.
Publicado: (2015)

PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia
por: Taynton, Thomas, et al.
Publicado: (2022)

Telomeres get SIRT-ified
por: Short, Ben
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_isptr0r2gm0o4fq2h7fcgepkhr